基本信息
浏览量:2
职业迁徙
个人简介
Research area
The Nanoparticle Systems Engineering Lab is focused on the design and development of nanoparticle-enabled approaches addressing clinical needs in disease etiology, diagnostics and drug delivery. We engineer nanoparticle-based systems based on design specs defined by clinical needs. By combining experimental and modelling approaches, we strive to obtain a holistic understaning of the materials-biology interplay across scale in order to rationally adjust the materials design. We have expertise in nanoparticle synthesis and functionalization, characterization and multiscale imaging of particle-based systems, as well as translational nanomedicine.
Inge Herrmann is a chemical engineer with additional training in (pre)clinical research. After graduating with a PhD from ETH Zurich, she underwent further training at the University Hospital Zurich (USZ), the University of Illinois (US) and the Imperial College London (UK). Since 2015, she is heading a research group at Empa specialized on nanoscale materials and devices for healthcare. In 2019, Inge Herrmann joined the Department of Mechanical and Process Engineering at ETH Zurich where she is heading the Nanoparticle Systems Engineering Lab. She is an expert in nanoparticle synthesis and characterization, spectromicroscopy and translational nanomedicine. She has spearheaded several translational nanomedicine projects, and serves as a scientific advisor of the spin-off companies hemotune, anavo and veltist commercializing technologies emerging from her lab. Inge Herrmann has won various prestigious awards, including the Bayer Healthcare Award and the Johnson & Johnson Award, the Swiss National Science Foundation Eccellenza Grant, the Empa Innovation Award and has been named Emerging Investigator 2021 by the Royal Society of Chemistry. Students and postdocs under her supervision have won major scientific and entrepreneurial awards, including the Best Master Thesis awarded by the Swiss Nanoscience Institute, ETH’s best doctoral thesis in the area of materials and processes (MaP) and ETH Pioneer Fellowships. She serves on the executive board of the ETH SFA Personalized Medicine and Related Technologies program and is an elected member of the research commission of the Swiss Laboratories for Materials Science and Technology (Empa). She is principle investigator (PI) of several national and international projects supported by the Swiss National Science Foundation, the Personalized Health and Related Technologies Initiative (PHRT), the Novartis FreeNovation program and several medical foundations (incl. the Swiss Heart Foundation, Krebsliga and many others).
The Nanoparticle Systems Engineering Lab is focused on the design and development of nanoparticle-enabled approaches addressing clinical needs in disease etiology, diagnostics and drug delivery. We engineer nanoparticle-based systems based on design specs defined by clinical needs. By combining experimental and modelling approaches, we strive to obtain a holistic understaning of the materials-biology interplay across scale in order to rationally adjust the materials design. We have expertise in nanoparticle synthesis and functionalization, characterization and multiscale imaging of particle-based systems, as well as translational nanomedicine.
Inge Herrmann is a chemical engineer with additional training in (pre)clinical research. After graduating with a PhD from ETH Zurich, she underwent further training at the University Hospital Zurich (USZ), the University of Illinois (US) and the Imperial College London (UK). Since 2015, she is heading a research group at Empa specialized on nanoscale materials and devices for healthcare. In 2019, Inge Herrmann joined the Department of Mechanical and Process Engineering at ETH Zurich where she is heading the Nanoparticle Systems Engineering Lab. She is an expert in nanoparticle synthesis and characterization, spectromicroscopy and translational nanomedicine. She has spearheaded several translational nanomedicine projects, and serves as a scientific advisor of the spin-off companies hemotune, anavo and veltist commercializing technologies emerging from her lab. Inge Herrmann has won various prestigious awards, including the Bayer Healthcare Award and the Johnson & Johnson Award, the Swiss National Science Foundation Eccellenza Grant, the Empa Innovation Award and has been named Emerging Investigator 2021 by the Royal Society of Chemistry. Students and postdocs under her supervision have won major scientific and entrepreneurial awards, including the Best Master Thesis awarded by the Swiss Nanoscience Institute, ETH’s best doctoral thesis in the area of materials and processes (MaP) and ETH Pioneer Fellowships. She serves on the executive board of the ETH SFA Personalized Medicine and Related Technologies program and is an elected member of the research commission of the Swiss Laboratories for Materials Science and Technology (Empa). She is principle investigator (PI) of several national and international projects supported by the Swiss National Science Foundation, the Personalized Health and Related Technologies Initiative (PHRT), the Novartis FreeNovation program and several medical foundations (incl. the Swiss Heart Foundation, Krebsliga and many others).
研究兴趣
论文共 129 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2024)
Robert Nissler, Elena Totter,Sebastian G. Walter,Justus T. Metternich,Oscar Cipolato, Dimitri Nowack,Alexander Gogos,Inge K. Herrmann
Advanced Healthcare Materialsno. 10 (2024)
Oscar Cipolato, Tobias Leuthold, Marius Zäch, Georg Maennel, Sam Aegerter, Calinda Sciascia, Alexander Jessernig,Sima Sarcevic,Jachym Rosendorf,Vaclav Liska, Dennis Kundrat,Romain Quidant,Inge K. Herrmann
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Michael-Alexander Pais, MD,Athanasios Papanikolaou, MD,Isabel Arenas Hoyos, MD, Robert Nißler, PhD,Simone de Brot, PhD,Alexander Gogos, PhD,Robert Rieben, Prof.,Mihai A. Constantinescu, Prof., MD,Martin T. Matter, PhD,Inge K. Herrmann, Prof.,Ioana Lese, MD
Plastic and reconstructive surgery Global openno. S5 (2024): 69-70
Robert Nißler, Elena Totter,Sebastian G. Walter,Justus T. Metternich, Oscar Cipolato, Dimitri Nowack,Alexander Gogos,Inge K. Herrmann
Advanced healthcare materials/Advanced Healthcare Materialsno. 10 (2024)
Sebastian Habermann,Lukas R H Gerken, Mathieu Kociak, Christian Monachon,Vera M Kissling,Alexander Gogos,Inge K Herrmann
Small (Weinheim an der Bergstrasse, Germany)pp.e2404309-e2404309, (2024)
Frontiers in bioengineering and biotechnology (2024)
Oscar Cipolato, Matthias Fauconneau, Paige J. LeValley,Robert Nißler, Benjamin Suter,Inge K. Herrmann
biorxiv(2024)
Alexandre H. C. Anthis,Samuel Kilchenmann, Manon Murdeu,Paige J. LeValley, Morris Wolf, Charlotte Meyer,Oscar Cipolato,Mark W. Tibbitt,Jachym Rosendorf,Vaclav Liska,Thomas Rduch,Inge K. Herrmann
Advanced materialsno. 23 (2024)
加载更多
作者统计
#Papers: 130
#Citation: 2473
H-Index: 26
G-Index: 47
Sociability: 6
Diversity: 0
Activity: 2
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn